The National Institute on Drug Abuse (NIDA), one of the renowned constituents of the National Institutes of Health announced here today of its decision to change the name of its scientific journal Perspectives to the Journal of Addiction Science & Clinical Practice, from the very November issue. In accordance with the proclamation it has also been learnt that the new title has been designed for the betterment of the reflection of the journal's commitment for a better exposure of the exchange of ideas between an array of researchers, clinicians, and others in the field of addiction science. It ha also been affirmed, that henceforth the NIDA will be augmenting the number of issues per year from once to twice a year, so as to provide accommodation for the growing necessity of the inclusion scientific literature more that are being produced in the expanding field of drug abuse and addiction research.

While talking to the concerned echelon in charge of the Journal, it has been learnt that from this time forth, The Journal of Addiction Science & Clinical Practice, the changed name shall also be included into the periphery of the Na tional Library of Medicine's MEDLINE (Medical Literature Analysis and Retrieval System Online) database, while at the same time enhancing the coterie of authority regarding the findings and insights of the contributors. But what is the USP or Unique Selling Proposition of the magazine and the reason of its special status where as there are so many of the same type in the marketplace?   The Addiction Science & Clinical Practice is committed mainly in the promotion of a dialogue between the scientists and an addiction with the intention of the improvement of the drug abuse treatment and research. In addition the special coverages of the journal on the subjects of the exchange of information, observations, and insights in a broader aspect helps the medical practitioners to exploit their programs and treatment outcomes at the greatest extent. In addition the researchers are also provided with the requisite devices for the development of new hypotheses and design studies that tend to be relevant to gratify the demands of both the providers and the patients.            

While asked to comment Dr. Nora D. Volkow, Director of NIDA said,   "Changing the name to The Journal of Addiction Science & Clinical Practice reflects our ongoing commitment to bringing the latest in addiction science from the laboratory to clinical field as quickly as possible."